7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Medical Condition

Disseminated İntravascular Coagulation

HematologyICD-10: D65
Disseminated İntravascular Coagulation
Condition at a Glance
ICD-10 codeD65
SpecialtyHematology

Quick answer

Disseminated intravascular coagulation is a serious condition in which the body’s clotting system becomes overactive, causing widespread tiny blood clots and, at the same time, an increased risk of bleeding. Treatment focuses on urgent hospital care to identify and manage the underlying trigger, support blood clotting and organ function, and monitor the patient closely with intensive laboratory and clinical assessment.

What is disseminated intravascular coagulation?

Disseminated intravascular coagulation, often shortened to DIC, is a serious condition in which the blood’s clotting system becomes overactive throughout the body. Instead of forming clots only where they are needed — for example, to seal a cut — the blood starts to form many small clots inside blood vessels in different organs at the same time. The word “disseminated” means widespread, “intravascular” means inside the blood vessels, and “coagulation” means clotting.

To understand what is disseminated intravascular coagulation, it helps to know that clotting normally works in careful balance. The body uses clotting factors (proteins in the blood) and platelets (small cell fragments that help plug damaged vessels) to stop bleeding, and it also has systems that dissolve clots when they are no longer needed. In DIC, this balance breaks down. Widespread clotting uses up the body’s platelets and clotting factors faster than they can be replaced. As a result, a person with DIC can have two problems at once: dangerous clots blocking blood flow to organs, and serious bleeding because the ingredients needed to stop bleeding have been used up.

Disseminated intravascular coagulation is not a disease that appears on its own. It is almost always a complication of another severe illness or injury, such as severe infection (sepsis), major trauma, certain cancers, or complications of pregnancy and childbirth. It can affect people of any age, from newborns to older adults, because it depends on the underlying trigger rather than on age itself. DIC is most often seen in hospitalized patients who are already seriously ill, and it is considered a medical emergency. In international coding systems it is listed under ICD-10 code D65.

DIC can develop suddenly over hours (acute DIC) or slowly over weeks or months (chronic DIC). Acute DIC tends to cause dramatic bleeding, while chronic DIC — which is more often linked to cancers — may cause fewer obvious symptoms and lean more toward clotting problems.

Symptoms of disseminated intravascular coagulation

Disseminated intravascular coagulation symptoms vary widely depending on how quickly the condition develops, which organs are affected, and whether bleeding or clotting is the dominant problem at that moment. Because DIC occurs in people who are usually already very ill, its symptoms often appear alongside those of the underlying condition.

Common bleeding-related symptoms may include:

  • Unusual bruising — bruises that appear without a clear cause, or that are larger than expected.
  • Small red or purple spots on the skin — called petechiae (tiny pinpoint spots) or purpura (larger patches), caused by bleeding under the skin.
  • Bleeding from multiple sites — such as the gums, nose, or from places where needles, catheters, or surgical wounds have broken the skin. Oozing from intravenous line sites is a classic sign in hospitalized patients.
  • Blood in the urine or stool — stool may look black or tarry if bleeding occurs in the digestive tract.
  • Heavy or prolonged bleeding — for example, after childbirth, surgery, or even minor injuries.

Clot-related symptoms depend on where the small clots block blood flow, and may include:

  • Shortness of breath or chest pain — if clots affect the lungs or heart.
  • Confusion, headache, or changes in speech or movement — if blood flow to the brain is reduced.
  • Reduced urine output — a possible sign that the kidneys are affected.
  • Pain, swelling, or discoloration in an arm or leg — which can suggest a clot in a deep vein.
  • Cool, pale, or bluish fingers or toes — when small vessels in the skin are blocked; in severe cases, areas of skin tissue can die (a condition sometimes called purpura fulminans).

In acute DIC, bleeding is usually the most visible problem, and it can become severe very quickly. In chronic DIC, symptoms are often subtler: a person may have repeated blood clots, mild bruising, or abnormal laboratory results without dramatic bleeding. Some people with chronic DIC have few or no symptoms, and the condition is discovered on blood tests done for other reasons.

Because these symptoms overlap with many other conditions, they cannot confirm DIC by themselves. Any pattern of unexplained bleeding or clotting, especially in someone who is already unwell, needs urgent medical assessment.

Causes and risk factors

Disseminated intravascular coagulation causes always involve an underlying condition that abnormally activates the clotting system. The trigger releases or exposes substances — most importantly a protein called tissue factor — that switch on clotting throughout the bloodstream instead of only at a site of injury.

The most common triggers include:

  • Severe infection and sepsis — sepsis is the body’s overwhelming, dangerous response to infection, and it is one of the most frequent causes of DIC. Bacterial infections are the classic trigger, but severe viral, fungal, or parasitic infections can also cause it.
  • Major trauma and burns — extensive tissue damage, especially head injury, crush injuries, and large burns, releases substances that activate clotting.
  • Cancer — certain cancers, including some leukemias (cancers of the blood-forming cells) and solid tumors such as those of the pancreas, stomach, or prostate, can cause acute or chronic DIC. Acute promyelocytic leukemia is particularly known for triggering severe DIC.
  • Pregnancy and childbirth complications — such as placental abruption (the placenta separating from the womb too early), amniotic fluid entering the mother’s bloodstream, severe preeclampsia (a dangerous blood-pressure disorder of pregnancy), a retained dead fetus, and severe bleeding after delivery.
  • Severe transfusion or immune reactions — including reactions to incompatible blood transfusions.
  • Severe liver disease — the liver makes most clotting factors, and severe liver failure can contribute to a DIC-like picture.
  • Venomous bites — some snake venoms directly activate the clotting system.
  • Major surgery, shock, and severe pancreatitis — inflammation of the pancreas and states of very low blood pressure can also act as triggers.
  • Severe heatstroke and certain vascular abnormalities — including large abnormal blood vessels or aneurysms in some cases.

Risk factors for developing DIC therefore largely mirror these causes. People who are critically ill in intensive care, who have recently had major surgery or trauma, who have advanced cancer, or who are experiencing serious complications of pregnancy are at the highest risk. DIC is not inherited and is not contagious; it is a complication, not a condition someone is born with.

Diagnosis

Disseminated intravascular coagulation diagnosis relies on a combination of the clinical picture — an underlying condition known to cause DIC plus signs of abnormal bleeding or clotting — and a panel of blood tests. There is no single test that proves or rules out DIC on its own; doctors interpret several results together, often repeating them over time to see the trend.

Blood tests commonly used include:

  • Platelet count — platelets are typically low in DIC because they are being consumed in the widespread clotting. A falling platelet count over serial tests is especially suggestive.
  • Prothrombin time (PT) and activated partial thromboplastin time (aPTT) — these measure how long the blood takes to clot in the laboratory. In DIC they are often prolonged, reflecting the depletion of clotting factors.
  • Fibrinogen level — fibrinogen is a key clotting protein that is used up in DIC, so its level is often low, particularly in acute DIC.
  • D-dimer and fibrin degradation products — these are breakdown fragments produced when clots dissolve. They are typically markedly raised in DIC, showing that clots are forming and breaking down throughout the body.
  • Blood smear — examining the blood under a microscope may show fragmented red blood cells (schistocytes), which are damaged as they pass through vessels partly blocked by clots.

Doctors often combine these results using a scoring system, such as the one developed by the International Society on Thrombosis and Haemostasis (ISTH), which assigns points based on the platelet count, clotting times, fibrinogen, and D-dimer. A score above a defined threshold supports the diagnosis of overt DIC, while lower scores may indicate early or non-overt DIC that needs monitoring.

Because DIC is always secondary to another problem, an important part of the diagnostic workup is identifying the underlying cause. Depending on the situation, this may involve blood cultures and other infection tests, imaging studies such as ultrasound or CT scans to look for hidden infection, bleeding, or tumors, and obstetric assessment in pregnant patients. Chronic DIC can be harder to recognize, because the body may partially compensate; in these cases, mildly abnormal results and a raised D-dimer in a person with a known trigger, such as cancer, may point to the diagnosis.

Treatment options

Disseminated intravascular coagulation treatment has one central principle: treat the underlying cause. Because DIC is a complication of another condition, the clotting abnormality usually cannot be controlled unless the trigger is addressed. Alongside this, doctors provide supportive care to manage bleeding and clotting while the body recovers. Treatment almost always takes place in a hospital, and in acute DIC often in an intensive care unit. Care is typically shared between the team managing the underlying illness and blood specialists; in many hospital systems, including the Hematology Department at Acibadem, hematologists (doctors who specialize in blood disorders) help guide the management of DIC.

Treating the underlying condition. This differs from patient to patient. It may mean antibiotics and source control for sepsis, delivery of the baby and control of bleeding in obstetric DIC, surgery or stabilization for trauma, or cancer-directed therapy such as chemotherapy for leukemia-related DIC. In many cases, once the trigger is controlled, the clotting system gradually returns toward normal.

Replacement of blood components. When a person is bleeding, or is at high risk of bleeding before a procedure, doctors may transfuse blood products to replace what has been consumed:

  • Platelet transfusions — to raise a low platelet count.
  • Fresh frozen plasma — the liquid part of donated blood, which contains clotting factors.
  • Cryoprecipitate or fibrinogen concentrate — concentrated sources of fibrinogen and certain other clotting proteins, used when fibrinogen is very low.
  • Red blood cell transfusions — if significant blood loss has caused anemia.

These transfusions are generally guided by laboratory results and the presence of active bleeding, rather than given automatically, because unnecessary transfusion carries its own risks.

Anticoagulant medication. This may seem counterintuitive in a condition that can cause bleeding, but in selected patients — particularly those in whom clotting is the dominant problem, such as some cases of chronic DIC or DIC with large clots — doctors may cautiously use anticoagulants (blood-thinning medications) such as heparin. The decision requires careful weighing of clotting risk against bleeding risk and is made individually by the treating team.

Supportive and monitoring care. Patients with acute DIC often need close monitoring of vital signs, oxygen levels, kidney function, and repeated blood tests. Supportive measures may include intravenous fluids, oxygen, medications to support blood pressure, and, in severe cases, organ support such as dialysis (a machine that filters the blood when the kidneys fail) or mechanical ventilation.

What about watchful waiting and surgery? In mild or chronic DIC without bleeding or serious clotting, doctors may choose careful observation with repeated blood tests while treating the underlying condition, rather than giving transfusions or anticoagulants. Surgery is not a treatment for DIC itself, but operations may be needed to address the trigger — for example, to remove a source of infection or to control bleeding after childbirth. In rare cases where blocked blood vessels have caused severe tissue damage, surgical treatment of the affected tissue may become necessary.

There is no single medication that “cures” DIC. Its management is a balancing act, adjusted continuously as the patient’s condition and laboratory results change.

Living with disseminated intravascular coagulation and outlook

The outlook for a person with disseminated intravascular coagulation depends mainly on the underlying cause, how quickly it is recognized and treated, and the person’s overall health. DIC itself is a serious condition, and acute DIC in the setting of sepsis, major trauma, or advanced cancer can be life-threatening. At the same time, many people recover fully once the underlying trigger is successfully treated — for example, after an obstetric complication is resolved or an infection is brought under control. It is honest to say that outcomes vary widely, and no doctor can guarantee a particular result.

Recovery from an episode of acute DIC often follows the recovery from the illness that caused it. Blood counts and clotting tests usually normalize gradually as the trigger resolves. Some people need time to regain strength after a critical illness, and follow-up blood tests are commonly arranged to confirm that the clotting system has stabilized. If organs such as the kidneys were affected during the acute episode, additional follow-up may be needed.

For people with chronic DIC — most often related to cancer — living with the condition usually means ongoing monitoring and management alongside treatment of the underlying disease. This may involve regular blood tests, and in some cases long-term anticoagulant medication to reduce the risk of clots. Practical points that doctors often discuss include recognizing signs of bleeding or clotting early, being cautious with activities that carry a high risk of injury while clotting is abnormal, informing all healthcare providers (including dentists) about the condition and any blood-thinning medication, and asking before taking new medicines or supplements, since some — such as aspirin and certain anti-inflammatory drugs — can increase bleeding risk.

Because DIC does not recur on its own, a person who has recovered is not automatically at risk of another episode unless a new trigger occurs. However, anyone who has had DIC should mention it to their doctors in the future, particularly before surgery or during pregnancy, so that their care team can plan accordingly.

Frequently asked questions

What is disseminated intravascular coagulation in simple terms?

It is a condition in which the blood’s clotting system is switched on throughout the body instead of only where it is needed. Many small clots form inside blood vessels, which can block blood flow to organs, and the process uses up platelets and clotting proteins so quickly that serious bleeding can also occur. It is always triggered by another severe condition, such as sepsis, major trauma, cancer, or a complication of pregnancy.

How serious is disseminated intravascular coagulation?

DIC is considered a medical emergency, especially in its acute form, because it can cause severe bleeding and organ damage at the same time. How dangerous it is in a given person depends largely on the underlying cause, how early it is recognized, and how well the trigger responds to treatment. Some cases are life-threatening, while others — particularly milder or chronic forms — can be managed with monitoring and treatment of the underlying disease.

Can disseminated intravascular coagulation be cured?

DIC itself usually resolves when the condition that triggered it is successfully treated. In that sense, many people recover completely — for example, after an infection is controlled or an obstetric complication is managed. However, there is no single drug that cures DIC directly, and if the underlying cause cannot be fully treated, as with some advanced cancers, DIC may persist in a chronic form and require ongoing management.

What are the first symptoms of disseminated intravascular coagulation?

Early disseminated intravascular coagulation symptoms often include unexplained bruising, tiny red or purple spots on the skin, and oozing or bleeding from the gums, nose, wounds, or intravenous line sites. Some people first show signs of clotting instead, such as shortness of breath, confusion, reduced urine output, or a painful swollen limb. In chronic DIC, there may be few or no obvious symptoms, and the condition is found on blood tests.

How do doctors diagnose disseminated intravascular coagulation?

Doctors confirm the diagnosis using a combination of the clinical situation and blood tests, including the platelet count, clotting times (PT and aPTT), fibrinogen level, and D-dimer. These results are often combined in a scoring system and repeated over time, because the trend can be more informative than a single result. Additional tests and imaging are used to find the underlying cause, since DIC does not occur on its own.

How long does recovery from disseminated intravascular coagulation take?

There is no fixed timeline, because recovery depends on the underlying illness. When the trigger is treated quickly and effectively, clotting tests often begin to improve within days, though full recovery from the associated critical illness can take longer. If organs such as the kidneys were affected, additional recovery time and follow-up may be needed. Your medical team can give you a more individualized picture based on your situation.

Which specialist treats disseminated intravascular coagulation?

DIC is usually managed by a team. The doctors treating the underlying condition — for example, intensive care physicians, obstetricians, oncologists, or surgeons — work together with hematologists, who specialize in blood and clotting disorders. In hospital settings, hematology departments typically advise on transfusion decisions, anticoagulant use, and the interpretation of clotting tests during and after an episode of DIC.

When to see a doctor

Disseminated intravascular coagulation usually develops in people who are already seriously ill, but its warning signs can appear or worsen quickly. Seek emergency medical care right away if you or someone with you has any of the following, especially in the setting of infection, recent surgery, injury, cancer, or pregnancy:

  • Bleeding that will not stop — from the gums, nose, a wound, or any other site.
  • Widespread bruising or a spreading rash of red or purple spots that do not fade when pressed.
  • Blood in the urine, vomit, or stool, or black, tarry stools.
  • Heavy vaginal bleeding during pregnancy or after childbirth.
  • Sudden shortness of breath or chest pain.
  • Sudden confusion, severe headache, slurred speech, or weakness on one side of the body.
  • A painful, swollen, or discolored arm or leg, or fingers and toes turning pale, blue, or black.
  • Very little or no urine over several hours.
  • Signs of severe infection — such as high fever with shaking chills, a racing heartbeat, dizziness, or feeling extremely unwell — combined with any unusual bleeding or bruising.

If you have previously had DIC, or you have a condition known to trigger it, tell any doctor treating you — including before surgery, dental procedures, or during pregnancy — so that your care team can monitor your clotting and respond early if problems develop. Unexplained bleeding or clotting is never something to watch and wait on at home; prompt evaluation gives the best chance of identifying and treating the cause before complications become severe.

Add Acıbadem on Google

Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.

Share this page

Medically reviewed by the Acıbadem International Medical Board — September 3, 2026
See our medical review board →

Published: June 14, 2026Last updated: September 2, 2026
Update history
  • PublishedJune 14, 2026
  • Medical review approvedSeptember 3, 2026
  • Last content updateSeptember 2, 2026
Treatments

Treatments for This Condition

Departments

Care at Acibadem

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.